Telmisartan NDC 62332-088

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-088Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0088Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62332-088-30	62332008830	30 TABLET in 1 BOTTLE (62332-088-30)Marketed from Jun 25, 2016
62332-088-91	62332008891	1000 TABLET in 1 BOTTLE (62332-088-91)Marketed from Jun 25, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Telmisartan
Generic name (nonproprietary): telmisartan
Active ingredients: Telmisartan — 40 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202130
Marketing start: Jun 25, 2016
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 62332-088_a12a8f1f-5c6e-423d-97de-549bde6225a1SPL ID a12a8f1f-5c6e-423d-97de-549bde6225a1SPL set ID c62d424c-7630-413c-be2c-3932831c3f1dRxCUI 205304, 205305, 282755UNII U5SYW473RQUPC 0362332087303, 0362332088300, 0362332089307
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332008830 followed by a unit qualifier and the quantity

Package 62332-0088-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 29, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Telmisartanis an angiotensin II receptor blocker (ARB) indicated for: • Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) • Cardiovascular (CV) risk reduction in patients unable to take ACE inhibitors ( 1.2 ) 1.1 Hypertension Telmisartan is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic c…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202130

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202130
Product	Strength	Form · route	Labeler	Product NDC
Telmisartan	Telmisartan 20 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-608
Telmisartan	Telmisartan 40 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-609
Telmisartan	Telmisartan 80 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-610
Telmisartan	Telmisartan 20 mg/1	TabletOral	Alembic Pharmaceuticals Inc.	62332-087
Telmisartan	Telmisartan 80 mg/1	TabletOral	Alembic Pharmaceuticals Inc.	62332-089